Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines

por Driscoll, Denise L., Chakravarty, Arijit, Bowman, Doug, Shinde, Vaishali, Lasky, Kerri, Shi, Judy, Vos, Tricia, Stringer, Bradley, Amidon, Ben, D'Amore, Natalie, Hyer, Marc L.
Publicado 2014

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

por Sato, Yosuke, Casson, Cierra N., Matsuda, Atsushi, Kim, James I., Shi, Judy Qiuju, Iwasaki, Shinji, Chen, Susan, Modrell, Brett, Chan, Chingkit, Tavares, Daniel, Austen, Douglas, Ida, Koh, Tayber, Olga, Hein, Pyae, Comeau, Robert, Lin, Yafang, Shaw, Michael H.
Publicado 2022

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies

por Carideo Cunniff, Elizabeth, Sato, Yosuke, Mai, Doanh, Appleman, Vicky A., Iwasaki, Shinji, Kolev, Vihren, Matsuda, Atsushi, Shi, Judy, Mochizuki, Michiyo, Yoshikawa, Masato, Huang, Jian, Shen, Luhua, Haridas, Satyajeet, Shinde, Vaishali, Gemski, Chris, Roberts, Emily R., Ghasemi, Omid, Bazzazi, Hojjat, Menon, Saurabh, Traore, Tary, Shi, Pu, Thelen, Tennille D., Conlon, Joseph, Abu-Yousif, Adnan O., Arendt, Christopher, Shaw, Michael H., Okaniwa, Masanori
Publicado 2022